Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hoskin

Showing results (71-80 of 241) with videos related to

Pageof 25
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 17, 2017
Efficacy of multiple fraction conventional radiation therapy for painful uncomplicated bone metastases: A systematic reviewRonald Chow, Peter Hoskin, Stephanie Chan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 3, 2016
Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancerLouise Murray, Joshua Mason, Ann M Henry, et al.
Journal of Medical Imaging and Radiation Sciences|February 21, 2025
Incidental findings in volunteer imaging used to develop radiotherapy MRI workflowsLisa McDaid, Anubhav Datta, Suzanne Bonington, et al.
Acta Oncologica (Stockholm, Sweden)|May 20, 2025
Quantifying the dosimetric impact of online daily adaptation for MR-guided RT in cervical cancerAmerah Alshamrani, Robert Chuter, Marianne Aznar, et al.
BMJ Oncology|January 31, 2025
Comparison of standard-dose and reduced-dose treatment of metastatic prostate cancer with enzalutamide, apalutamide or darolutamide: a rapid reviewHannah Louise Bromley, Mohini Varughese, Duncan C Gilbert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 21, 2002
International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastasesEdward Chow, Jackson S Y Wu, Peter Hoskin, et al.
Nature Reviews. Urology|August 27, 2024
Immune effects of α and β radionuclides in metastatic prostate cancerSapna Lunj, Tim Andrew Davies Smith, Kimberley Jayne Reeves, et al.
International Journal of Radiation Oncology, Biology, Physics|February 3, 2023
Pain Response Rates After Conventional Radiation Therapy for Bone Metastases Assessed Using International Consensus Pain Response Endpoints: A Systematic Review and Meta-Analysis of Initial Radiation Therapy and ReirradiationNobuki Imano, Tetsuo Saito, Peter Hoskin, et al.
JCO Global Oncology|October 20, 2020
Radical External-Beam Radiotherapy in Combination With Intracavitary Brachytherapy for Localized Carcinoma of the Cervix in Sri Lanka: Is Treatment Delayed Treatment Denied?Nuradh Joseph, Hasanthi Jayalath, Jayantha Balawardena, et al.
BMJ Open|April 18, 2024
<i>E</i>xploratory study of using <i>M</i>agnetic resonance <i>P</i>rognostic <i>I</i>maging markers for <i>R</i>adiotherapy <i>I</i>n <i>C</i>ervix cancer (EMPIRIC): a prospective cohort study protocolMohammed Abdul-Latif, Amani Chowdhury, Hannah Tharmalingam, et al.
Pageof 25

Showing results (71-80 of 241) with videos related to

Sort By:
Pageof 25
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 17, 2017
Efficacy of multiple fraction conventional radiation therapy for painful uncomplicated bone metastases: A systematic reviewRonald Chow, Peter Hoskin, Stephanie Chan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 3, 2016
Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancerLouise Murray, Joshua Mason, Ann M Henry, et al.
Journal of Medical Imaging and Radiation Sciences|February 21, 2025
Incidental findings in volunteer imaging used to develop radiotherapy MRI workflowsLisa McDaid, Anubhav Datta, Suzanne Bonington, et al.
Acta Oncologica (Stockholm, Sweden)|May 20, 2025
Quantifying the dosimetric impact of online daily adaptation for MR-guided RT in cervical cancerAmerah Alshamrani, Robert Chuter, Marianne Aznar, et al.
BMJ Oncology|January 31, 2025
Comparison of standard-dose and reduced-dose treatment of metastatic prostate cancer with enzalutamide, apalutamide or darolutamide: a rapid reviewHannah Louise Bromley, Mohini Varughese, Duncan C Gilbert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 21, 2002
International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastasesEdward Chow, Jackson S Y Wu, Peter Hoskin, et al.
Nature Reviews. Urology|August 27, 2024
Immune effects of α and β radionuclides in metastatic prostate cancerSapna Lunj, Tim Andrew Davies Smith, Kimberley Jayne Reeves, et al.
International Journal of Radiation Oncology, Biology, Physics|February 3, 2023
Pain Response Rates After Conventional Radiation Therapy for Bone Metastases Assessed Using International Consensus Pain Response Endpoints: A Systematic Review and Meta-Analysis of Initial Radiation Therapy and ReirradiationNobuki Imano, Tetsuo Saito, Peter Hoskin, et al.
JCO Global Oncology|October 20, 2020
Radical External-Beam Radiotherapy in Combination With Intracavitary Brachytherapy for Localized Carcinoma of the Cervix in Sri Lanka: Is Treatment Delayed Treatment Denied?Nuradh Joseph, Hasanthi Jayalath, Jayantha Balawardena, et al.
BMJ Open|April 18, 2024
<i>E</i>xploratory study of using <i>M</i>agnetic resonance <i>P</i>rognostic <i>I</i>maging markers for <i>R</i>adiotherapy <i>I</i>n <i>C</i>ervix cancer (EMPIRIC): a prospective cohort study protocolMohammed Abdul-Latif, Amani Chowdhury, Hannah Tharmalingam, et al.
Pageof 25